Skip to content

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. The Lancet. Published online, 12 February 2015 - Please find attached analysis of the recent published paper in The Lancet which discusses HRT and ovarian cancer risk.This includes: A statement from IMS President, Dr Rodney Baber outlining the IMS position. A… Read More

HRT Excellence Days

29-30th March 2014 - HRT Excellence Days - an international collaboration between IMS, the Russian Menopause Society, and Abbott Laboratories, Zhangzhou, ChinaPost meeting report, by Tobie de Villiers, President, IMS Tobie de Villiers, President reports 'IMS provided the international speaker panel which included John Stevenson and new Board member Alfred Mueck. Qi Yu who is… Read More

HRT Excellence Days - an international collaboration between IMS, the EAU Menopause Society, and Abbott Laboratories

31st January 2014 - 1st Feburary 2014 - HRT Excellence Days - an international collaboration between IMS, the EAU Menopause Society, and Abbott Laboratories, Abu DhabiPost meeting report by Rodney Baber, President electIMS held an educational weekend on the menopause in Abu Dhabi, 31st January - 1st February 2014.Rod Baber, President - elect reports 'The… Read More

International Menopause Society

Install International Menopause Society - DEV

Install this application on your home screen for quick and easy access when you’re on the go.

Just tap then “Add to Home Screen”